Medical News
.jpg)
Reducing Cardiovascular Risk with Immunomodulators Among RA...
Ann. Rheum. Dis
Addition of either a TNFi or triple therapy resulted in clinically important improvements in vascular inflammation...
01 Dec 2022
Less than 1-year Quiescent Period after Septic Arthritis of...
J Arthroplasty
Less than 1-year quiescent period after septic arthritis is associated with at 38 times increased risk and 22 times...
25 Nov 2022
Combined Anterior and Posterior Approach in Treatment of Ank...
Eur. Spine J.
The results of this review and meta-analysis suggest that the benefits of the anterior–posterior approach are...
23 Nov 2022
Minimum 30 Year Results of Bilaterally Implanted Cemented an...
J Arthroplasty
Long-term fixation of the cemented or cementless femoral stem was outstanding. There was a high rate of the...
21 Nov 2022
eCMEs
Key Trials
PROOF Study: Effectiveness of Salmon Calcitonin Nasal Spray in Reducing Risk of New Vertebral Fractures in Osteoporotic Postmenopausal Women
PROOF study assessed the reduction in the risk of new vertebral fractures with salmon calcitonin nasal spray treatment in postmenopausal women with...
Incidence of Osteosarcoma in Patients with History of Teriparatide Treatment
This is a post-marketing surveillance study aimed to determine the osteosarcoma incidence in patients with a history of teriparatide treatment. The...
Efficacy of Teriparatide on Prior Use to Lumbar Fusion Surgery in Patients with Poor Bone Health
The present study assessed the two-year complication rates for patients who have poor bone health, with or without teriparatide pre-treatment before...
Risk MACE or Cancers with Tofacitinib verses TNF Inhibitor in RA Patients
This study assessed the risk of cardiovascular disease and cancer with tofacitinib and TNF inhibitor in patients with rheumatoid arthritis. The...
Patient Education
Osteoporosis:Video
The public awareness video gives an overview of osteoporosis and its management in patient friendly visuals and language.
General Awareness on Hydroxychloroquine Tablets
This educational input provides patient counselling information as per prescribing information on Hydroxychloroquine tablets regarding its therapeuti...
General Awareness on Methotrexate Tablets
This educational input provides patient counselling information as per prescribing information on methotrexate tablets regarding its therapeutic usag...
General Awareness on Tofacitinib Tablets
This educational input provides patient counselling information as per prescribing information on Tofacitinib tablets regarding its therapeutic usage...
Our Publications
Zotide (Teriparatide ) Monograph
The currently available pharmacological treatments for osteoporosis are predominantly anti-resorptive. These inhibit osteoclast-mediated bone loss...
Hyruan (Hyaluronic Acid) Monograph
Osteoarthritis (OA) is the most common form of arthritis and is a major cause of debilitation for affected individuals. One of the nonsurgical...
Calcinase (calcitonin) – Monograph
This monograph covers various aspects of osteoporosis management and pharmacology, clinical efficacy & safety of calcitonin in treatment of...
Imutrex (methotrexate) – Getting to the Heart of Rheumatoid Arthritis Abstracts Booklet
This publication features efficacy & safety studies of methotrexate in management of rheumatoid arthritis.
Slide Library
Intraarticular Hyaluronic acid for Osteoarthirits
The presentation includes description of synovial hyaluronic acid, its viscoelastic property, mechanism of action and different types available in...
Osteoarthritis
This presentation shows the structure of bone joint majorly affected in osteoarthritis, its pathophysiology, risk factors, signs and symptoms and...
Recommendations for Up & Downscaling of Methotrexate Dose in Rheumatoid Arthritis
Methotrexate (MTX) is the first-line treatment for early and clearly defined rheumatoid arthritis (RA). This presentation summarizes the...
Musculoskeletal Manifestations of Ulcerative Colitis
This slide set covers the common musculoskeletal manifestations of inflammatory bowel diseases (IBD) and its management. The spectrum of these...
.jpg)
Poll
Which of the following bisphosphonate is preferred as first line treatment of osteoporosis-
Alendronate
Risedronate
Ibandronate
Zoledronic acid
Total votes: 8